ABSORB III Randomized Controlled Trial (RCT)

Completed · Not applicable

Conditions studied: Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Stenosis

In brief

The ABSORB III RCT is a prospective randomized, single-blind, multi-center trial. It is the pivotal trial to support the US pre-market approval (PMA) of Absorb™ Bioresorbable Vascular Scaffold (BVS). The ABSORB III includes additional two trials i.e. ABSORB III PK (pharmacokinetics) sub-study and ABSORB IV RCT trial which are maintained under one protocol because both trial designs are related, ABSORB IV is the continuation of ABSORB III and the data from ABSORB III and ABSORB IV will be pooled to support the ABSORB IV primary endpoint. Both the trials will evaluate the safety and effectiveness of Absorb BVS.

Key facts

Study ID
NCT01751906
Run by
Abbott Medical Devices
People needed
2008
Starts
2012-12-01
Expected to finish
2020-10-01
Last updated by the study team
2023-10-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.